Li Yang
- Nephrology top 0.2%
- Acute Kidney Injury Research 38
- Chronic Kidney Disease and Diabetes 27
- Renal Diseases and Glomerulopathies 24
- Dialysis and Renal Disease Management 7
- Pharmaceutical Science top 1%
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation 7
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection 9
- Molecular Biology top 5%
-
- Nephrotoxicity and Medicinal Plants 14
-
- Electrochemical sensors and biosensors 6
Li Yang
156 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Nephrology 1.5k
- Pharmaceutical Science 257
- Critical Care and Intensive Care Medicine 127
- Pharmacology 198
- Molecular Biology 1.4k
Countries citing papers authored by Li Yang
This map shows the geographic impact of Li Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Yang more than expected).
Fields of papers citing papers by Li Yang
This network shows the impact of papers produced by Li Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Yang. The network helps show where Li Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 9 | |
| 9 | 2022 | 20 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 5 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 105 | |
| 14 | 2018 | 15 | |
| 15 | 2018 | 1 | |
| 16 | 2016 | 98 | |
| 17 | [Clinical features, quality of life and psychological health of patients with irritable bowel syndrome and functional dyspepsia]. | 2014 | 2 |
| 18 | 2013 | 39 | |
| 19 | 2013 | 18 | |
| 20 | 2012 | 43 |
About Li Yang
Li Yang is a scholar working on Nephrology, Critical Care and Intensive Care Medicine, Pharmacology, Transplantation and Radiology, Nuclear Medicine and Imaging, having authored 172 papers that have together received 4.5k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (38 papers), Chronic Kidney Disease and Diabetes (27 papers), Renal Diseases and Glomerulopathies (24 papers), Nephrotoxicity and Medicinal Plants (14 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (7 papers), Dialysis and Renal Disease Management (7 papers) and Electrochemical sensors and biosensors (6 papers). The work is most often cited by research in Nephrology (1.5k citations), Pharmaceutical Science (257 citations), Critical Care and Intensive Care Medicine (127 citations), Pharmacology (198 citations) and Molecular Biology (1.4k citations). Li Yang has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Joseph V. Bonventre, Craig R. Brooks, Tatiana Y. Besschetnova, Jagesh V. Shah, Yue Cui, Xiaojin Luo, Suxia Wang, Qi Yu, Xiao‐Li Tian and Yiqun Liu. Their work appears in journals such as BMC Nephrology, Journal of the American Society of Nephrology, PLoS ONE, Journal of Clinical Medicine and Frontiers in Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.